Rs495828 polymorphism of the ABO gene is a predictor of enalapril-induced cough in Chinese patients with essential hypertension

Pharmacogenetics and Genomics

Volumn 24, Issue 6, 2014, Pages 306-313

  Luo, Jian Quan ^a   He, Fa Zhong ^a   Luo, Zhi Ying ^a   Wen, Jia Gen ^a   Wang, Lu Yan ^b   Sun, Ning Ling ^b   Tang, Gen Fu ^c   Li, Qing ^a   Guo, Dong ^a   Liu, Zhao Qian ^a   Zhou, Hong Hao ^a   Chen, Xiao Ping ^a   Zhang, Wei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

ABO; cough; enalapril; essential hypertension; polymorphism

Indexed keywords

ENALAPRIL MALEATE; BLOOD GROUP ABO SYSTEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ABO GENE; ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; COUGHING; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GROUP ABO SYSTEM; CHEMICALLY INDUCED; GENETIC ASSOCIATION; GENETICS; HYPERTENSION; PATHOLOGY;

ABO BLOOD-GROUP SYSTEM; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; COUGH; ENALAPRIL; FEMALE; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 84900521243     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0000000000000050     Document Type: Article

References (40)

1. Tseng DS, Kwong J, Rezvani F, Coates AO. Angiotensin-converting enzymerelatedcough among Chinese-Americans. Am J Med 2010 123:111-183.
2. Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensinconverting enzyme inhibitors in Chinese. Br J Clin Pharmacol 199540:141-144.
3. Elliott WJ. Higher incidence of discontinuation of angiotensin convertingenzyme inhibitors due to cough in black subjects. Clin Pharmacol Ther1996 60:582-588.
4. Tumanan-Mendoza BA, Dans AL, Villacin LL, Mendoza VL, Rellama-Black S,Bartolome M, et al. Dechallenge and rechallenge method showed differentincidences of cough among four ACE-Is. J Clin Epidemiol 2007 60:547-553.
5. Woo SW, Bang S, Chung MW, Jin SK, Kim YS, Lee SH. Lack of associationbetween ACE and bradykinin B2 receptor gene polymorphisms and ACEinhibitor-induced coughing in hypertensive Koreans. J Clin Pharm Ther2009 34:561-567.
6. Lee YJ, Tsai JC. Angiotensin-converting enzyme gene insertion/deletion, notbradykinin B2 receptor-58T/C gene polymorphism, associated withangiotensin-converting enzyme inhibitor-related cough in Chinese femalepatients with non-insulin-dependent diabetes mellitus. Metabolism 200150:1346-1350.
7. Mukae S, Aoki S, Itoh S, Iwata T, Ueda H, Katagiri T.Bradykinin B(2) receptor gene polymorphism is associated with angiotensinconvertingenzyme inhibitor-related cough. Hypertension 2000 36:127-131.
8. Zee RY, Rao VS, Paster RZ, Sweet CS, Lindpaintner K. Three candidategenes and angiotensin-converting enzyme inhibitor-related cough: apharmacogenetic analysis. Hypertension 1998 31:925-928.
9. Grilo A, Saez-Rosas MP, Santos-Morano J, Sanchez E, Moreno-Rey C,Real LM, et al. Identification of genetic factors associated with susceptibilityto angiotensin-converting enzyme inhibitors-induced cough. PharmacogenetGenomics 2011 21:10-17.
10. Mas S, Gasso P, Alvarez S, Ortiz J, Sotoca JM, Francino A, et al.Pharmacogenetic predictors of angiotensin-converting enzyme inhibitorinducedcough: the role of ACE, ABO, and BDKRB2 genes.Pharmacogenet Genomics 2011 21:531-538.
11. Li YF, Zhu XM, Liu F, Xiao CS, Bian YF, Li H, et al. Angiotensin- convertingenzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitorrelatedcough: a meta-analysis. PLoS One 2012 7:e37396.
12. Mahmoudpour SH, Leusink M, van der Putten L, Terreehorst I, AsselbergsFW, de Boer A, et al. Pharmacogenetics of ACE inhibitor-inducedangioedema and cough: a systematic review and meta-analysis.Pharmacogenomics 2013 14:249-260.
13. Nishio K, Kashiki S, Tachibana H, Kobayashi Y. Angiotensin- convertingenzyme and bradykinin gene polymorphisms and cough: a meta-analysis.World J Cardiol 2011 3:329-336.
14. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. Aninsertion/deletion polymorphism in the angiotensin I-converting enzymegene accounting for half the variance of serum enzyme levels. J Clin Invest1990 86:1343-1346.
15. De Denus S. Pharmacogenomic testing for angiotensin-converting enzymeinhibitors: getting ready for prime time. Pharmacogenomics 201011:1345-1348.
16. Chung CM,Wang RY, Chen JW, Fann CS, Leu HB, Ho HY, et al. A genomewideassociation study identifies new loci for ACE activity: potentialimplications for response to ACE inhibitor. Pharmacogenomics J 201010:537-544.
17. Cidl K, Strelcova L, Znojil V, Vachi J. Angiotensin I-converting enzyme (ACE)polymorphism and ABO blood groups as factors codetermining plasmaACE activity. Exp Hematol 1996 24:790-794.
18. Yamamoto F, McNeill PD, Hakomori S. Genomic organization of humanhisto-blood group ABO genes. Glycobiology 1995 5:51-58.
19. Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, et al.Large-scale association analysis identifies 13 new susceptibility loci forcoronary artery disease. Nat Genet 2011 43:333-338.
20. Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, et al.Identification of ADAMTS7 as a novel locus for coronary atherosclerosis andassociation of ABO with myocardial infarction in the presence of coronaryatherosclerosis: two genome-wide association studies. Lancet 2011377:383-392.
21. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB,et al. Large-scale genomic studies reveal central role of ABO in sP-selectinand sICAM-1 levels. Hum Mol Genet 2010 19:1863-1872.
22. Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, Sun Q, et al. Geneticvariants in ABO blood group region, plasma soluble E-selectin levels andrisk of type 2 diabetes. Hum Mol Genet 2010 19:1856-1862.
23. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM,Carter RE, et al. Genome-wide association identifies the ABO blood groupas a major locus associated with serum levels of soluble E-selectin.Arterioscler Thromb Vasc Biol 2009 29:1958-1967.
24. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. A partition- ligationcombination-subdivision EM algorithm for haplotype inference withmultiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res2009 19:519-523.
25. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkagedisequilibrium, haplotype construction, and genetic association atpolymorphism loci. Cell Res 2005 15:97-98.
26. Dicpinigaitis PV, Rauf K. The influence of gender on cough reflex sensitivity.Chest 1998 113:1319-1321.
27. Sitkauskiene B, Stravinskaite K, Sakalauskas R, Dicpinigaitis PV. Changes incough reflex sensitivity after cessation and resumption of cigarette smoking.Pulm Pharmacol Ther 2007 20:240-243.
28. Gasso P, Mas S, Alvarez S, Ortiz J, Sotoca JM, Francino A, et al. A commonvariant of the ABO gene protects against hypertension in a Spanishpopulation. Hypertension Res 2012 35:592-596.
29. Heit JA, Armasu SM, Asmann YW, Cunningham JM, Matsumoto ME,Petterson TM, et al. A genome-wide association study of venousthromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.J Thromb Haemost 2012 10:1521-1531.
30. Hong KW, Moon S, Kim YJ, Kim YK, Kim DJ, Kim CS, et al. Associationbetween the ABO locus and hematological traits in Korean. BMC Genet2012 13:78.
31. Nakao M, Matsuo K, Ito H, Shitara K, Hosono S, Watanabe M, et al. ABOgenotype and the risk of gastric cancer, atrophic gastritis, and Helicobacterpylori infection. Cancer Epidemiol Biomarkers Prev 2011 20:1665-1672.
32. Desch KC, Ozel AB, Siemieniak D, Kalish Y, Shavit JA, Thornburg CD, et al.Linkage analysis identifies a locus for plasma von Willebrand factorundetected by genome-wide association. Proc Natl Acad Sci USA 2013110:588-593.
33. Patnaik SK, Helmberg W, Blumenfeld OO. BGMUT: NCBI dbRBCdatabase of allelic variations of genes encoding antigens of blood groupsystems. Nucleic Acids Res 2012 40:D1023-D1029.
34. Zhu H, Pan J. Distribution of ABO alleles polymorphism in Zhejiang Hanpopulation. Zhejiang Univ 2009 4:19-23.
35. Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, et al. Novelassociation of ABO histo-blood group antigen with soluble ICAM-1: resultsof a genome-wide association study of 6,578 women. PLoS Genet 20084:e1000118.
36. Shigematsu S, Ishida S, Gute DC, Korthuis RJ. Bradykinin- inducedproinflammatory signaling mechanisms. Am J Physiol Heart Circ Physiol2002 283:H2676-H2686.
37. Pare G, Ridker PM, Rose L, Barbalic M, Dupuis J, Dehghan A, et al.Genome-wide association analysis of soluble ICAM-1 concentration revealsnovel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci. PLoSGenet 2011 7:e1001374.
38. Naitza S, Porcu E, Steri M, Taub DD, Mulas A, Xiao X, et al. A genome-wideassociation scan on the levels of markers of inflammation in Sardiniansreveals associations that underpin its complex regulation. PLoS Genet2012 8:e1002480.
39. Kiechl S, Pare G, Barbalic M, Qi L, Dupuis J, Dehghan A, et al. Associationof variation at the ABO locus with circulating levels of soluble intercellularadhesion molecule-1, soluble P-selectin, and soluble E-selectin: a metaanalysis.Circ Cardiovasc Genet 2011 4:681-686.
40. Ye RJ, He QY, Gai J, Shang Y. A prospective study on the coughmechanism induced by angiotensin-converting enzyme inhibitors inpatients with hypertension. Zhonghua Jie He He Hu Xi Za Zhi 200427:581-584.